about
Correction: Silica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 ProteinSilica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 ProteinTransition metal sulfides grown on graphene fibers for wearable asymmetric supercapacitors with high volumetric capacitance and high energy densityUnderstanding effect of wall structure on the hydrothermal stability of mesostructured silica SBA-15.Advances in silica based nanoparticles for targeted cancer therapy.Electron-tomography determination of the packing structure of macroporous ordered siliceous foams assembled from vesicles.TiO(2)-modified macroporous silica foams for advanced enrichment of multi-phosphorylated peptides.Solving hierarchical helical mesostructures by electron tomography.Enrichment and detection of peptides from biological systems using designed periodic mesoporous organosilica microspheres.Laser engineered graphene paper for mass spectrometry imaging.One-pot synthesis of hierarchical FeZSM-5 zeolites from natural aluminosilicates for selective catalytic reduction of NO by NH3Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.Mesoporous Magnesium Oxide Hollow Spheres as Superior Arsenite Adsorbent: Synthesis and Adsorption Behavior.Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement.Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells.Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression SystemMesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.Applications of nanomaterials in mass spectrometry analysis.Nanoparticle vaccines.Mesoporous materials modified by aptamers and hydrophobic groups assist ultra-sensitive insulin detection in serum.Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity.Curcumin-cyclodextrin encapsulated chitosan nanoconjugates with enhanced solubility and cell cytotoxicity.Silencing of E6/E7 expression in cervical cancer stem-like cells.Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein.Dual-Functional Ultrafiltration Membrane for Simultaneous Removal of Multiple Pollutants with High Performance.Facile synthesis and characterization of novel mesoporous and mesorelief oxides with gyroidal structures.Structure transition from hexagonal mesostructured rodlike silica to multilamellar vesicles.Stepwise pore size reduction of ordered nanoporous silica materials at angstrom precision.New insight into ordered cage-type mesostructures and their pore size determination by electron tomography.An approach to prepare polyethylenimine functionalized silica-based spheres with small size for siRNA delivery.Asymmetric mesoporous silica nanoparticles as potent and safe immunoadjuvants provoke high immune responses.Nanoengineering of Core-Shell Magnetic Mesoporous Microspheres with Tunable Surface Roughness.Plasmid DNA Delivery: Nanotopography Matters.On the origin of helical mesostructures.Oxidative Dissolution of Resoles: A Versatile Approach to Intricate Nanostructures.A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.Kinetically Controlled Assembly of Nitrogen-Doped Invaginated Carbon Nanospheres with Tunable Mesopores.Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance.
P50
Q27331842-5B13F8F1-9B52-418D-AF26-BEDFEF2AD8F5Q27340109-CF944715-B383-4683-84DC-334B063852EDQ27349141-586D15CA-8109-4E90-BBAF-72A942134E4BQ33250807-2F9FD4BB-E0F9-4073-AE31-74E8597F4F76Q33362192-E0C2D085-EB25-4089-B698-6D5491FE772BQ33400441-6D3DE55E-54AC-4B65-A2E1-D1B5A4BAC92BQ33405305-EC71FD3E-1AEA-42EF-9F55-A9D4EB9E5E11Q33533570-1C846C0F-D0E9-4D8F-AC1A-515F68BD22A8Q34089146-6F95CC75-179E-4A33-AE82-C800116E452EQ34615660-393BA96E-5709-4328-ACC1-095BBB56C92AQ35198190-953B018F-1FA9-4FE3-ACF7-080A306EF6C0Q35999402-948589DC-5DCC-4C1C-A1F0-745B73C0EC8EQ36124350-F5161E5A-BA29-4ED1-8FEC-5B5AC595765DQ36200987-31B68B62-26E4-4956-B334-72A9F2227E93Q36356052-09DEAA0C-7003-4A9D-A939-533A719730A9Q37594405-8708F226-9394-48B9-B9E9-1DDAED6DBB30Q38105259-7672F0F1-5D84-4474-A774-6D3F57550661Q38155738-47CA67A4-DFCD-4FFD-B806-5EB2ACF381B5Q38167942-CA305C88-7337-4718-8883-3D41DACF4BA4Q38297335-EBA742E4-0B07-47C0-B2AA-9219FE2C77F6Q38962156-85CE38A4-CE00-4048-A1B6-74B737B9AE3EQ39008491-1D93E3DB-C47E-480B-8A8F-B4CAF9198142Q39107508-71A9A713-F6AB-4985-8DF8-EB4F44858FD4Q39257381-D85F7C12-8C95-4FA9-8F7F-1B2FEC780DBBQ39386703-5FD15F4A-EF30-4FC5-A091-96F9AE754A9BQ42186720-40D13F1E-986D-4B98-B132-519DC3716388Q43361802-E67671F4-1BCB-4DA7-9DDC-C40B651CF634Q44735088-9233BCDF-9F86-4DBC-B830-01CA80FB3166Q46695256-8131FC23-FA14-45A2-BE50-F4BFA12CE9B3Q47235679-5BA93FE3-BDF8-4E50-B550-79D998A8EF4FQ47407009-5249884C-0ED3-48CC-88F6-BCC5E8663485Q47438888-7114D939-AFB1-443B-B6B5-9F58F77C9284Q48090635-8705BC12-F9F8-40FE-9EDC-D3DFC703426EQ48145410-D373F836-CA3B-4D17-AB85-160E30991E04Q48277017-890ADC53-3833-4FBD-A8F6-8B9CF1C2CA29Q48435843-B51FF7A4-0A35-4920-BE86-4359D50B2552Q48602937-38CF8A38-EE15-4C19-BE47-D1198B4F131AQ48922465-BE65C4E1-CC51-4255-B8B0-C1169EFBF7B9Q49068552-7984C2A8-15C1-4482-A31C-A2B646471923Q49959001-C91A0B91-7D8D-4BC5-B86A-5E153416119E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chengzhong Yu
@ast
Chengzhong Yu
@en
Chengzhong Yu
@es
Chengzhong Yu
@nl
Chengzhong Yu
@sl
type
label
Chengzhong Yu
@ast
Chengzhong Yu
@en
Chengzhong Yu
@es
Chengzhong Yu
@nl
Chengzhong Yu
@sl
prefLabel
Chengzhong Yu
@ast
Chengzhong Yu
@en
Chengzhong Yu
@es
Chengzhong Yu
@nl
Chengzhong Yu
@sl
P1053
I-8663-2012
P106
P1153
7404977977
P166
P31
P3829
P496
0000-0003-3707-0785
P569
2000-01-01T00:00:00Z